Studies led by Domenico Praticò, professor of pharmacology and microbiology and immunology in Temple’s School of Medicine, have found that controlling or inhibiting the brain enzyme 5-lipoxygenase could be a key to controlling the two proteins that are major brain pathological signatures for Alzheimer’s disease.